Evidence map›Paper›PMID 34161550›Full record

ArticleRevista do Instituto de Medicina Tropical de Sao Paulo2021

Endothelial activation is associated with albuminuria in multibacillary leprosy.

Louise Donadello Tessarolo, Gdayllon Cavalcante Meneses, Gabriela Freire Bezerra, Thaiany Pereira da Rocha, Isabella Evelyn Prado de Azevedo, Geraldo Bezerra Silva Junior, Maria Araci Andrade Pontes, Elizabeth De Francesco Daher, Alice Maria Costa Martins

Open access · diamondAbstract read
In one paragraph

Article in Revista do Instituto de Medicina Tropical de Sao Paulo, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Louise Donadello TessaroloUniversidade Federal do Ceará, Faculdade de Farmácia, Departamento de Análises Clínicas e Toxicológicas, Programa de Pós-Graduação em Ciências Farmacêuticas, Fortaleza, Ceará, Brazil.ORCID http://orcid.org/0000-0003-2104-6334
Gdayllon Cavalcante MenesesUniversidade Federal do Ceará, Faculdade de Medicina, Departamento de Medicina Clínica, Programa de Pós-Graduação em Ciências Médicas, Fortaleza, Ceará, Brazil.ORCID http://orcid.org/0000-0002-0160-5728
Gabriela Freire BezerraUniversidade Federal do Ceará, Faculdade de Medicina, Departamento de Fisiologia e Farmacologia, Programa de Pós-Graduação em Farmacologia, Fortaleza, Ceará, Brazil.ORCID http://orcid.org/0000-0002-0798-1396
Thaiany Pereira da RochaUniversidade Federal do Ceará, Faculdade de Farmácia, Departamento de Análises Clínicas e Toxicológicas, Programa de Pós-Graduação em Ciências Farmacêuticas, Fortaleza, Ceará, Brazil.
Isabella Evelyn Prado de AzevedoUniversidade Federal do Ceará, Faculdade de Farmácia, Departamento de Análises Clínicas e Toxicológicas, Programa de Pós-Graduação em Ciências Farmacêuticas, Fortaleza, Ceará, Brazil.ORCID http://orcid.org/0000-0002-7047-9091
Geraldo Bezerra Silva JuniorUniversidade de Fortaleza, Centro de Ciências da Saúde, Faculdade de Medicina, Programa de Pós-Graduação de Saúde Coletiva, Fortaleza, Ceará, Brazil.ORCID http://orcid.org/0000-0002-8971-0994
Maria Araci Andrade PontesHospital Dona Libânia, Fortaleza, Ceará, Brazil.ORCID http://orcid.org/0000-0002-7292-8452
Elizabeth De Francesco DaherUniversidade Federal do Ceará, Faculdade de Medicina, Departamento de Medicina Clínica, Programa de Pós-Graduação em Ciências Médicas, Fortaleza, Ceará, Brazil.ORCID http://orcid.org/0000-0003-4189-1738
Alice Maria Costa MartinsUniversidade Federal do Ceará, Faculdade de Farmácia, Departamento de Análises Clínicas e Toxicológicas, Programa de Pós-Graduação em Ciências Farmacêuticas, Fortaleza, Ceará, Brazil.ORCID http://orcid.org/0000-0001-8160-2027
Universidade Federal do Ceará · BRInstituto de Dermatologia Dona Libania · BRUniversidade de Fortaleza · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leprosy may present kidney and endothelial abnormalities, being a risk factor for complications. However, the involvement of renal and vascular endothelia has been poorly investigated. We aimed to investigate if the levels of systemic endothelial biomarkers are associated with kidney abnormalities and the clinical forms of leprosy. This is a cross-sectional study with leprosy patients enrolled in January 2017 to December 2018, before the initiation of the multidrug therapy. Leprosy-associated clinical and epidemiological data were collected. Two groups were investigated: Paucibacillary (PB) and Multibacillary (MB) infections, for the comparisons. Serum and urine samples were obtained for laboratory analysis. In serum samples, were evaluated the endothelial biomarkers VCAM-1 and ICAM-1. In total, 101 leprosy patients were included, the mean age was 48±١٥ years and 71 (70%) were male. The multibacillary form occurred in 81 cases (80%), among which 22 had the Virchowian form. Serum creatinine was more elevated in the MB group than in PB patients. In addition, VCAM-1 was elevated in the MB group and was correlated with the bacteriological index (rho = 0.372, p <0.01), the duration of disease symptoms (rho = 0.234, p = 0.04), and the number of skin lesions (rho = 0.468, p <0.001). Moreover, in MB patients who presented albuminuria >15 mg/g of creatinine, VCAM-1 showed a significant correlation with increased albuminuria and improved the correlation with the number of skin lesions (rho= 0.563, p=0.010). In conclusion, higher systemic VCAM-1 levels were associated with the multibacillary clinical form of leprosy and with increased albuminuria. Prospective studies are necessary to establish a cause-effect and evaluate the preventive role of these biomarkers to improve the clinical care.

Indexed as

AlbuminuriaLeprosy, MultibacillaryCross-Sectional StudiesDrug Therapy, CombinationHumansLeprostatic AgentsMaleMiddle AgedProspective StudiesLeprostatic Agents

Identifiers

PMID34161550
PMCPMC8216693
OpenAlexW3177149087

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.